The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease
NCT01720628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2012-11-02
Summary
Objectives: Behçet's disease (BD) is a systemic vasculitis. Since vascular endothelial dysfunction plays a prominent role in the pathogenesis of the disease, we considered angiogenic cytokines as an interesting target for investigation in BD. The aim of this study was to investigate the possible role of angiogenin, vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in the pathogenesis of BD.
Design and Methods: Sixty five patients with BD and 21 healthy control subjects were included in the study. Serum angiogenin, bFGF and VEGF concentrations were determined by using in vitro enzyme immunoassay (ELISA) kits according to the manufacturer's instructions.
Conditions
- Behçet's Disease
Interventions
- OTHER
-
serum levels of angiogenin, bFGF, VEGF
Behçet's patients
Sponsors & Collaborators
-
Turkish Ophthalmology Society
lead OTHER
Principal Investigators
-
ali yalçındağ · * Dışkapı Yıldırım Beyazıt Training and Research Hospital, Department of Clinical Biochemistry
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2011-11-30
- Completion
- 2012-02-29
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Withdrawal of Colchicine in Behçet Syndrome
NCT06146192 ·Status: NOT_YET_RECRUITING
-
IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
NCT05128357 ·Status: UNKNOWN
-
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
NCT04105439 ·Status: UNKNOWN
-
Role of Regulatory B Cells in Behçet's Disease
NCT04376411 ·Status: COMPLETED
-
Behçet's Disease and Eosinophil Cationic Protein
NCT01584778 ·Status: COMPLETED
-
Aetiology of TemporaL Arteritis Study
NCT02584517 ·Status: WITHDRAWN
-
Tocilizumab and Tofacitinib in the Treatment of Vascular Behçet's Syndrome
NCT05845723 ·Status: RECRUITING ·Phase: PHASE2
-
Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
NCT00315393 ·Status: COMPLETED
-
Research of Biomarkers Associated With the Diagnosis and Severity of Bradykinin Angioedema
NCT04963634 ·Status: TERMINATED
-
Clinical, Laboratory, and Therapeutic Analysis of Behçet's Disease in Assiut
NCT07157189 ·Status: NOT_YET_RECRUITING
-
Reproductive Health in Men and Women With Vasculitis
NCT02176070 ·Status: COMPLETED
-
Cytokines in Blister Fluids of Bullous Pemphigoid (BP)
NCT03856840 ·Status: COMPLETED
-
PRO Development for ANCA Associated Vasculitis
NCT01729624 ·Status: UNKNOWN
-
Pediatric Vasculitis Initiative
NCT02006134 ·Status: RECRUITING
-
38 Week Extension Study to CAIN457C2303
NCT01093846 ·Status: TERMINATED ·Phase: PHASE3
-
Vasculitis Illness Perception (VIP) Study
NCT02190916 ·Status: COMPLETED
-
Biocollection of Patients With ANCA Associated Vasculitis
NCT05364892 ·Status: RECRUITING ·Phase: NA
-
One-Time DNA Study for Vasculitis
NCT01241305 ·Status: RECRUITING
-
1 Year of Treatment With Canakinumab in Behçet's Disease Patients With Neurologic or Vascular Involvement
NCT02756650 ·Status: COMPLETED ·Phase: PHASE2
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Belimumab in Remission of VASculitis
NCT01663623 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers in Giant Cells Arteritis
NCT02844023 ·Status: TERMINATED ·Phase: NA
-
A Study of Efficacy and Safety of Hemay005 Tablets in Patients With Behçet's Disease
NCT06145893 ·Status: RECRUITING ·Phase: PHASE3
-
VCRC Patient Contact Registry Patient-Reported Data Validation Study
NCT02190942 ·Status: COMPLETED
-
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
NCT03209219 ·Status: COMPLETED ·Phase: PHASE3